Wei-Chun Ko1, Yee-Fan Lee1, Yi-Chang Chen1, Ning Chien1, Yu-Sen Huang1, Yao-Hui Tseng1, Jang-Ming Lee2, Hsao-Hsun Hsu2, Jin-Shing Chen3, Yeun-Chung Chang1. 1. Department of Medical Imaging, National Taiwan University Hospital, Taipei, Taiwan. 2. Division of Thoracic Surgery, Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan. 3. Division of Thoracic Surgery, Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan; Department of Traumatology, National Taiwan University Hospital, Taipei, Taiwan.
Abstract
BACKGROUND: Microwave ablation (MWA) of lung tumors is a new approach for local tumor control. The purpose of this retrospective study was to evaluate the preliminary results of safety and efficacy of MWA with a dynamic frequency range (902-928 MHz) and power (10-32 W) for local tumor control of thoracic malignancies. METHODS: From December 1, 2013 to February 1, 2016, there were total 32 lung tumors among 15 patients (7 men, 8 women, age range 43-82 years, mean 57.8±11.1 years of age) receiving MWA of thoracic neoplasms, including lung adenocarcinoma (n=5), metastatic colorectal cancer (n=7), invasive thymoma (n=1), metastatic uterine leiomyosarcoma (n=1), and metastatic ampullary carcinoma (n=1). Mean tumor size was 13.5 mm (range, 3.0-32.0 mm). The mean sequential ablation during each MWA was 2.3±1.1 times (range, 1-5 times). The outcomes of ablation were evaluated by follow-up computed tomography (CT) scans and the complications were assessed by medical records and CT scan after ablation. RESULTS: The mean follow-up interval of each tumor was 446.8 days (range, 196-902 days). Local tumor recurrence was found in 5 of the 32 tumors resulting in a local control rate 84.4%. No MWA-related mortality was noted. After MWA, the incidence of pneumothorax was 37.5% (12/32). Only one patient with pneumothorax required air evacuation. Third-degree skin burn adjacent to the entry site occurred in one patient and required debridement and closure with flap. CONCLUSIONS: After appropriate patient selection, MWA with a dynamic frequency range (902-928 MHz) and power (10-32 W) is an effective and safe procedure for local tumor control of recurrent and metastatic lung tumors.
BACKGROUND: Microwave ablation (MWA) of lung tumors is a new approach for local tumor control. The purpose of this retrospective study was to evaluate the preliminary results of safety and efficacy of MWA with a dynamic frequency range (902-928 MHz) and power (10-32 W) for local tumor control of thoracic malignancies. METHODS: From December 1, 2013 to February 1, 2016, there were total 32 lung tumors among 15 patients (7 men, 8 women, age range 43-82 years, mean 57.8±11.1 years of age) receiving MWA of thoracic neoplasms, including lung adenocarcinoma (n=5), metastatic colorectal cancer (n=7), invasive thymoma (n=1), metastatic uterine leiomyosarcoma (n=1), and metastatic ampullary carcinoma (n=1). Mean tumor size was 13.5 mm (range, 3.0-32.0 mm). The mean sequential ablation during each MWA was 2.3±1.1 times (range, 1-5 times). The outcomes of ablation were evaluated by follow-up computed tomography (CT) scans and the complications were assessed by medical records and CT scan after ablation. RESULTS: The mean follow-up interval of each tumor was 446.8 days (range, 196-902 days). Local tumor recurrence was found in 5 of the 32 tumors resulting in a local control rate 84.4%. No MWA-related mortality was noted. After MWA, the incidence of pneumothorax was 37.5% (12/32). Only one patient with pneumothorax required air evacuation. Third-degree skin burn adjacent to the entry site occurred in one patient and required debridement and closure with flap. CONCLUSIONS: After appropriate patient selection, MWA with a dynamic frequency range (902-928 MHz) and power (10-32 W) is an effective and safe procedure for local tumor control of recurrent and metastatic lung tumors.
Authors: Thomas J Vogl; Nagy N N Naguib; Tatjana Gruber-Rouh; Karen Koitka; Thomas Lehnert; Nour-Eldin A Nour-Eldin Journal: Radiology Date: 2011-11 Impact factor: 11.105
Authors: U Pastorino; M Buyse; G Friedel; R J Ginsberg; P Girard; P Goldstraw; M Johnston; P McCormack; H Pass; J B Putnam Journal: J Thorac Cardiovasc Surg Date: 1997-01 Impact factor: 5.209
Authors: Damian E Dupuy; Hiran C Fernando; Shauna Hillman; Thomas Ng; Angelina D Tan; Amita Sharma; William S Rilling; Kelvin Hong; Joe B Putnam Journal: Cancer Date: 2015-06-19 Impact factor: 6.860
Authors: Farrah J Wolf; David J Grand; Jason T Machan; Thomas A Dipetrillo; William W Mayo-Smith; Damian E Dupuy Journal: Radiology Date: 2008-03-27 Impact factor: 11.105
Authors: Hiroshi Kodama; Eisuke Ueshima; Song Gao; Sebastien Monette; Lee-Ronn Paluch; Kreg Howk; Joseph P Erinjeri; Stephen B Solomon; Govindarajan Srimathveeravalli Journal: Int J Hyperthermia Date: 2018-04-18 Impact factor: 3.914
Authors: Joyce W Y Chan; Rainbow W H Lau; Jenny C L Ngai; Carita Tsoi; Cheuk Man Chu; Tony S K Mok; Calvin S H Ng Journal: Transl Lung Cancer Res Date: 2021-04
Authors: Shanda H Blackmon; Rosalie M Sterner; Patrick W Eiken; Thomas J Vogl; Bradley B Pua; Jeffrey L Port; Damian E Dupuy; Matthew R Callstrom Journal: J Thorac Dis Date: 2021-12 Impact factor: 2.895